This study aims to describe the characteristics of patients with metastatic or recurrent cervical cancer as well as why and what types of treatments are given.

Registered study from PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024). Evidence status: source reported.

Organisation

Analytica Laser (Certara company)

Published

2020-06-25

Source reference

ODR1920_039

Jurisdiction

England

Licence

Open Government Licence v3.0 (Public Health England, © Crown copyright 2020)

Applicant: Analytica Laser (Certara company) · Commercial organisation · Data: National Cancer Registration and Analysis Service · De-personalised data · Legal basis: No legal gateway required · Released 2020-06-25

Source: https://www.gov.uk/government/publications/phe-data-release-register. Captured 2026-10-30.

Limitations: A release as Public Health England's Office for Data Release recorded it, April 2017 to September 2020. It shows PHE data was released for the project, not what the project produced. Rows for the same reference are merged; amendments ("/A1") and renewals keep their own references. The free-text technical summary, purpose, benefits and funders columns are not stored. COVID-19 data shared through PHE's National Incident Coordination Centre is not included. The register was withdrawn in May 2022 and is not updated.